DK2809350T3 - STABILIZED Aqueous Antibody Preparations - Google Patents

STABILIZED Aqueous Antibody Preparations Download PDF

Info

Publication number
DK2809350T3
DK2809350T3 DK13703468.2T DK13703468T DK2809350T3 DK 2809350 T3 DK2809350 T3 DK 2809350T3 DK 13703468 T DK13703468 T DK 13703468T DK 2809350 T3 DK2809350 T3 DK 2809350T3
Authority
DK
Denmark
Prior art keywords
antibody
protein
aqueous solution
ethyleneimine
oligomer
Prior art date
Application number
DK13703468.2T
Other languages
Danish (da)
English (en)
Inventor
Guy Casy
Barry Kingston Derham
Jan Jezek
Nikki Royle
Original Assignee
Arecor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arecor Ltd filed Critical Arecor Ltd
Application granted granted Critical
Publication of DK2809350T3 publication Critical patent/DK2809350T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK13703468.2T 2012-01-30 2013-01-30 STABILIZED Aqueous Antibody Preparations DK2809350T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261592323P 2012-01-30 2012-01-30
PCT/GB2013/050211 WO2013114112A2 (en) 2012-01-30 2013-01-30 Stabilized aqueous antibody compositions

Publications (1)

Publication Number Publication Date
DK2809350T3 true DK2809350T3 (en) 2019-01-28

Family

ID=47681959

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13703468.2T DK2809350T3 (en) 2012-01-30 2013-01-30 STABILIZED Aqueous Antibody Preparations

Country Status (9)

Country Link
US (2) US10532098B2 (https=)
EP (1) EP2809350B1 (https=)
JP (1) JP2015506369A (https=)
CN (1) CN104203282A (https=)
CA (1) CA2861402C (https=)
DK (1) DK2809350T3 (https=)
ES (1) ES2705538T3 (https=)
IN (1) IN2014DN06121A (https=)
WO (1) WO2013114112A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2861402C (en) 2012-01-30 2021-10-12 Guy Casy Stabilized aqueous antibody compositions
BR112018016868B1 (pt) * 2016-02-19 2022-09-13 Avery Dennison Corporation Composições de adesivos e artigo compreendendo as mesmas
GB201613896D0 (en) 2016-08-12 2016-09-28 Arecor Ltd Novel composition
US11608357B2 (en) 2018-08-28 2023-03-21 Arecor Limited Stabilized antibody protein solutions
EP3372241A1 (en) 2017-03-06 2018-09-12 Ares Trading S.A. Liquid pharmaceutical composition
EP3372242A1 (en) 2017-03-06 2018-09-12 Ares Trading S.A. Liquid pharmaceutical composition
CN112672734B (zh) * 2018-09-10 2023-04-11 陶氏环球技术有限责任公司 包含蛋白质和聚烷氧基脂肪酰基表面活性剂的组合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5990237A (en) 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
DE19726186A1 (de) 1997-06-20 1998-12-24 Boehringer Ingelheim Int Komplexe für den Transport von Nukleinsäure in höhere eukaryotische Zellen
DE19933024C2 (de) 1999-07-15 2003-03-13 Medinnova Ges Med Innovationen Kationische Blockcopolymere
US6652886B2 (en) 2001-02-16 2003-11-25 Expression Genetics Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
ATE517926T1 (de) * 2003-04-04 2011-08-15 Yeda Res & Dev Antikörper zur hemmung der aktivität von mmp-2 und mmp-9
AU2004260935A1 (en) 2003-06-30 2005-02-10 Canji, Inc. Polymer encapsulation of adenoviruses
US7022214B2 (en) * 2004-01-21 2006-04-04 Bio-Rad Laboratories, Inc. Carrier ampholytes of high pH range
ES2569409T3 (es) 2005-03-08 2016-05-10 Pfizer Products Inc. Composiciones de anticuerpo anti-CTLA-4
WO2007133812A2 (en) 2005-12-30 2007-11-22 Philadelphia Health & Education Corporation, D/B/A Drexel University College Of Medicine Improved carriers for delivery of nucleic acid agents to cells and tissues
GB0700523D0 (en) 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins
US20080312174A1 (en) 2007-06-05 2008-12-18 Nitto Denko Corporation Water soluble crosslinked polymers
MX2011003074A (es) 2008-09-24 2011-04-19 Stabilitech Ltd Metodo para conservar polipeptidos utilizando un azucar y polietilenimina.
RU2011126338A (ru) * 2008-11-28 2013-01-10 Эбботт Лэборетриз Стабильные композиции антител и способы их стабилизации
CN102946858B (zh) * 2010-05-10 2015-09-30 英塔斯制药有限公司 含有免疫球蛋白Fc的多肽的液体制剂
EP2598167B1 (en) * 2010-07-30 2015-04-01 Arecor Limited Stabilized aqueous antibody compositions
CA2861402C (en) 2012-01-30 2021-10-12 Guy Casy Stabilized aqueous antibody compositions

Also Published As

Publication number Publication date
WO2013114112A3 (en) 2013-11-07
CA2861402C (en) 2021-10-12
EP2809350B1 (en) 2018-10-17
IN2014DN06121A (https=) 2015-08-14
CA2861402A1 (en) 2013-08-08
EP2809350A2 (en) 2014-12-10
US20200138946A1 (en) 2020-05-07
ES2705538T3 (es) 2019-03-25
US20150010548A1 (en) 2015-01-08
US10532098B2 (en) 2020-01-14
US12016922B2 (en) 2024-06-25
CN104203282A (zh) 2014-12-10
JP2015506369A (ja) 2015-03-02
WO2013114112A2 (en) 2013-08-08

Similar Documents

Publication Publication Date Title
EP2598167B1 (en) Stabilized aqueous antibody compositions
US12600763B2 (en) Compositions and methods for the delivery of therapeutic biologics for treatment of disease
US12016922B2 (en) Stabilized aqueous antibody compositions
EP3585360B1 (en) Stabilized antibody solutions
JP7278952B2 (ja) 安定化された抗体タンパク質溶液
US11608357B2 (en) Stabilized antibody protein solutions
EP3062814A1 (en) Antibody composition
US20200069799A1 (en) Stabilized antibody protein solutions
KR20250029029A (ko) 주사가능한 현탁액
AU2018258676A1 (en) N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
AU2020245573B2 (en) Methods of fingerprinting therapeutic proteins via a two-dimensional (2D) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products
US20230277453A1 (en) Stabilized antibody protein solutions
US20230414753A1 (en) Stabilized antibody protein solutions
WO2026080887A2 (en) Cd-40 targeting compositions and uses thereof